Industry
-
China-US tensions close in on Australia
- Mon Sep 28
As China looks to dominate innovative R&D, Australia must decide where it sits in the New World Order, and what it will pay to make that happen.
Read more -
MA Board candidates make their pitch
- Mon Sep 21
EXCLUSIVE: Nomination statements for all three candidates contesting two director vacancies on the Medicines Australia Board – published in full.
Read more -
How MFN hands MA exactly what it needs
- Mon Sep 21
Medicines Australia enters negotiations with more leverage than at any point in history, reshaping the stakes for government and the GBMA.
Read more -
The playbook guiding MA’s negotiations
- Fri Sep 18
Medicines Australia’s contracted negotiator outlines how his organisation helped ink a deal in the UK, including tactics and policy signals.
Read more -
MA picks up another new member
- Wed Sep 16
In arguably one of the biggest growth periods in Medicines Australia’s history, another big name pharma has returned after a six year hiatus.
Read more -
Four female leaders make big career moves
- Wed Sep 16
Four senior executive women have announced significant moves in their careers, including a former Aussie pharma MD and a senior NSW bureaucrat.
Read more -
Lights, camera, nominate: Hollywood enters Board race
- Mon Sep 14
Boehringer’s Ed Hollywood on why he’s standing for the MA Board and his ‘uncomfortable’ proposal for delivering better access to medicines.
Read more -
Australian pharma faces AI reality check
- Mon Sep 14
AI is boosting efficiency, but concerns are rising as people working in Aussie pharma start questioning its impact on long‑term job security.
Read more